3,5 disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation

Details for Australian Patent Application No. 2004259531 (hide)

Owner Pfizer Inc.

Inventors McAlpine, Indrawan James; Reich, Siegfried Heinz; Kephart, Susan Elizabeth

Agent Allens Arthur Robinson

Pub. Number AU-A-2004259531

PCT Pub. Number WO2005/009997

Priority 60/491,474 30.07.03 US; 60/492,073 31.07.03 US

Filing date 19 July 2004

Wipo publication date 3 February 2005

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009997 Priority application(s): WO2005/009997

15 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259537-Device for manufacturing a doublewalled thermoplastic pipe with a connecting sleeve

2004259526-Nicotinamide derivatives useful as PDE4 inhibitors